Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DR26F5N31
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,930
Award facts
- Contract value 100% obligated
- $40,930.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract valued at $40,930.40 to AmerisourceBergen Drug Corp for the supply of HUMIRA (Adalimumab) Pen 40 mg/0.4 mL, a biologic medication used to treat various inflammatory conditions including rheumatoid arthritis, Crohn's disease, and ulcerative colitis. This firm fixed-price delivery order, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical prime vendor agreement running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor headquartered in Pennsylvania, is well-positioned to fulfill this pharmaceutical procurement through its extensive portfolio of federal medical supply contracts with the Defense Logistics Agency and other government health systems. The company's federal contracting history demonstrates consistent capability in delivering specialized medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Department of Defense and veteran healthcare requirements. This delivery order represents a routine pharmaceutical procurement executed through the established prime vendor contract framework designed to ensure efficient and reliable medical supply chain support for military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F5N31?
SPE2DR26F5N31 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F5N31 worth?
The government has obligated $40,930 on SPE2DR26F5N31.
Is contract SPE2DR26F5N31 an order under another contract?
Yes. SPE2DR26F5N31 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5N31 competed?
The extent of competition for SPE2DR26F5N31 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award